$83.19 -0.55 (%) Eli Lilly & Co - NYSE

Aug. 28, 2015 | 04:00 PM

Partner Headlines

  1. Benzinga's Top Initiations

    Benzinga | Aug. 27, 2015 | 09:42AM EST
  2. U.S. District Court Rules in Lilly's Favor on Alimta Vitamin Regimen Patent

    Benzinga | Aug. 25, 2015 | 17:10PM EST
  3. Benzinga's Volume Movers

    Benzinga | Aug. 20, 2015 | 10:35AM EST
  4. Lilly Issues Update on Evacetrapib Phase 3 Trial: Last Patient Visit in ACCELERATE Expecting Jul. '16

    Benzinga | Jul. 27, 2015 | 08:01AM EST
  5. Biogen's Big-Volume Plunge Marks End Of 5-Year Run

    IBD | Jul. 24, 2015 | 13:26PM EST
  6. Valeant Posts Princely Gains

    IBD | Jul. 23, 2015 | 18:55PM EST
  7. 3 Big-Cap Drugmakers Who Beat Q2 Earnings Estimates

    IBD | Jul. 23, 2015 | 17:50PM EST
  8. Shire Lifts 2015 Guidance On Strong Drug Pipeline

    IBD | Jul. 23, 2015 | 14:42PM EST
  9. Lilly, Bristol-Myers Beat Q2 Views, Lift Guidance

    IBD | Jul. 23, 2015 | 10:58AM EST
  10. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  11. Wall Street Struggles for Direction After Two-Day Selloff

    FoxBusiness | Jul. 23, 2015 | 09:30AM EST
  12. Alzheimer's Data Diverge

    IBD | Jul. 22, 2015 | 18:49PM EST
  13. Biogen, Lilly Alzheimer's Data Spark Street Debate

    IBD | Jul. 22, 2015 | 12:07PM EST
  14. Are We Any Closer to Finding a Drug to Battle Alzheimer's?

    FoxBusiness | Jul. 22, 2015 | 11:46AM EST
  15. Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease

    Benzinga | Jul. 22, 2015 | 07:04AM EST
  16. Fast Money Picks For July 21

    Benzinga | Jul. 21, 2015 | 06:26AM EST
  17. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  18. Celgene Hits High As Street Applauds Receptos Buyout

    IBD | Jul. 15, 2015 | 11:12AM EST
  19. Manning & Napier Advisors' Most Weighted Trades in Q2 2015

    GuruFocus | Jul. 10, 2015 | 16:32PM EST
  20. Weekly 52-Week Highs Highlight: LLY, PLL, SBUX, VLO

    GuruFocus | Jul. 7, 2015 | 11:52AM EST
  21. Eli Lilly Shares Go Parabolic

    Benzinga | Jun. 25, 2015 | 11:08AM EST
  22. Stocks Cling To Thin Early Gains; Ambarella Bounces, Cree Dives

    IBD | Jun. 25, 2015 | 10:35AM EST
  23. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD | Jun. 24, 2015 | 15:49PM EST
  24. Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story

    GuruFocus | Jun. 22, 2015 | 18:34PM EST
  25. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  26. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 17:57PM EST
  27. Teva Migraine Drug Succeeds In Midstage Trial

    IBD | Jun. 18, 2015 | 12:27PM EST
  28. Benzinga's Top Initiations

    Benzinga | Jun. 17, 2015 | 09:29AM EST
  29. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus | Jun. 11, 2015 | 13:41PM EST
  30. New Migraine Drugs Could Ease Investors' Headaches

    IBD | Jun. 11, 2015 | 08:02AM EST
  31. What We Don't Know About Antibiotics Could Kill Us

    FoxBusiness | Jun. 11, 2015 | 05:00AM EST
  32. ImmunoGen Surprises, PD-1 Drugs Under Scrutiny At ASCO

    IBD | Jun. 1, 2015 | 17:48PM EST
  33. 4 Stocks Rising On ASCO Cancer Drug News

    IBD | Jun. 1, 2015 | 12:34PM EST
  34. Bristol Sinks On Lung Cancer Data; Merck Up On 2 Trials

    IBD | May. 29, 2015 | 16:22PM EST
  35. Lilly and Incyte Announce Webcast to Discuss Baricitinib Phase III Data

    Benzinga | May. 28, 2015 | 13:00PM EST
  36. Lilly to Present New Clinical Data at 75th American Diabetes Association Scientific Sessions

    Benzinga | May. 27, 2015 | 07:32AM EST
  37. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD | May. 26, 2015 | 12:39PM EST
  38. IPO Stock Watch: Alder Soars On Migraine Drug Results

    IBD | May. 15, 2015 | 16:31PM EST
  39. Vanguard Adds to Four of Its Largest Stakes

    GuruFocus | May. 4, 2015 | 19:24PM EST
  40. Biogen Making A Breakthrough In Treating Alzheimer's

    GuruFocus | May. 2, 2015 | 16:04PM EST
  41. 8 Dividend Stocks With The Right Qualities

    GuruFocus | Apr. 29, 2015 | 17:32PM EST
  42. MannKind Looks Good For Long Term Investors

    GuruFocus | Apr. 29, 2015 | 12:37PM EST
  43. Citigroup Upgrades Eli Lilly To Buy

    Benzinga | Apr. 29, 2015 | 08:57AM EST
  44. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  45. Eli Lilly

    IBD | Apr. 23, 2015 | 18:31PM EST
  46. US Stock Futures Down Ahead Of Earnings, Economic Data

    Benzinga | Apr. 23, 2015 | 08:14AM EST
  47. Eli Lilly Tops Q1 Views

    Benzinga | Apr. 23, 2015 | 07:18AM EST
  48. Eli Lilly Partner Deciphera Pharma Announces Data Highlighting Kinase Inhibitor Pipeline at AACR Meeting

    Benzinga | Apr. 22, 2015 | 08:05AM EST
  49. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  50. 5 'Key Pipeline Catalysts' To Watch At Eli Lilly

    Benzinga | Feb. 23, 2015 | 17:42PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!